Pharmaceuticals, Biotechnology and Life Sciences
Tiziana Life Sciences said Thursday it has developed investigational new technology to treat COVID-19 infections.
Dynavax Technologies Corporation said Wednesday it is donating 10,000 doses of HEPLISAV-B adult vaccine to help protect healthcare professionals on the front lines of the COVID-19 response against hepatitis B.
GlaxoSmithKline and Vir Biotechnology have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19, in which GSK will make an equity investment in Vir of $250 million, to gain access to Vir’s technology.
Oxford Biomedica said Wednesday it has joined a Consortium lead by the Jenner Institute, Oxford University, to work on a potential vaccine candidate for COVID-19, called ChAdOx1 nCov-19.
ACG has introduced its first-ever AI-based blister inspection system that offers you a plethora of benefits. Surpassing the challenges of conventional inspection systems, this new system can take your production efficiency to the next level, bringing machine interaction closer to human interaction.
Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets.
Care Access Research on Friday said it was leading a validation trial with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.
Switzerland-based ObsEva SA has nominated Fabien de Ladonchamps, Vice President Corporate Affairs & Finance, as interim Chief Financial Officer and member of the Executive Committee.
Novartis said on Thursday it aims to start a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for the treatment of a type of severe immune overreaction called cytokine storm that can lead to life-threatening respiratory complications in patients with COVID-19.